INTRODUCTION
The mucosal barrier plays an essential role in preventing infection by pathogens in the hen oviduct. We have previously reported that the synthesis of mucin, one of the members forming the mucosal barrier, decreased in the oviducts of molting hens compared with those in laying hens (Ariyadi et al., 2012) . Lipopolysaccharide (LPS), a component of the outer membrane of gram-negative bacteria, upregulated mucin expression in the oviduct of laying and molting hens (Ariyadi et al., 2013b) . These reports suggest that the mucosal barrier is enhanced by secreting mucin when gram-negative bacteria enter the oviduct. However, the mechanism by which mucin expression is upregulated by LPS in the oviductal mucosa remains unknown.
Toll-like receptors (TLR) recognize pathogen-associated molecular patterns and initiate innate immune responses (Kogut et al., 2005) . In chickens, genes of several types of TLR, namely, TLR1 to TLR5, TLR7, TLR15, and TLR21, have been identified (Temperley et al., 2008) . It is reported that TLR use adaptors of the myeloid differentiation factor 88 (MyD88)-or Toll-interleukin 1 receptor (TIR) domain-containing adaptorinducing IFN-β (TRIF) for activation of intracellular signal pathways (MyD88-and TRIF-dependent pathways, respectively). In mammals, TLR4 recognizes LPS (Kawai and Akira, 2010) and activates MyD88-and TRIF-dependent pathways (O'Neill and Bowie, 2007) . However, the TRIF-dependent pathway may not be activated by the interaction of TLR4 with LPS in chickens because the adaptor protein TRIF-related adaptor molecule (TRAM) that bridges TLR4 and TRIF may be lacking (Keestra et al., 2013) . At the end of the TLR signal pathway, nuclear factor-κB (NFκB) and mitogen-activated protein kinase (MAPK) are activated (Kogut et al., 2012) . The NFκB is activated by the breakdown of its inhibitor molecule (IκB), and the MAPK activates the activated protein 1 (AP1; cFos and cJun; Kogut et al., 2008 Kogut et al., , 2012 . The activated transcriptional factors, NFκB and AP1, are translocated into the nucleus to initiate the transcription of the target genes (Kawai and Akira, 2010 mucin by LPS in the hen oviduct is probably mediated by TLR4 and its signal pathways, leading to the activation of transcriptional factors. Previous studies have identified the expression of TLR4 in the hen oviduct and vagina (Ozoe et al., 2009; Michailidis et al., 2011) . However, it is unknown which signal pathway of TLR, namely, a MyD88-dependent or -independent pathway, is formed in the vaginal mucosa, and which transcriptional factor, NFκB or AP1, is responsible for mucin expression by LPS. The aim of this study was to determine the intracellular signaling molecules responsible for mucin induction by LPS, and the effects of molting and estrogen on their expression. Specific issues that were examined were as follows: 1) whether the expression of the TLR adaptor molecules and transcriptional factors is affected by the oviductal regression and estrogen, and 2) which transcriptional factor, NFκB or AP1, is involved in the mucin expression by LPS. In experiment 1, the expression of TLR4 and TLR adaptor molecules (MyD88 and TRIF), and transcriptional factors (NFκB, cFos, and cJun) were examined in laying and molting hens injected with or without estradiol. Expression of TLR4 was analyzed among different TLR because we focused on the cellular response to LPS. In experiment 2, we examined whether the induction of mucin expression by LPS was suppressed by inhibitors of NFκB, IκB proteolysis, MAPK, and AP1.
MATERIALS AND METHODS

Experimental Birds and Tissue Preparation
White Leghorn hens, approximately 500 d old and laying 4 or more eggs in a clutch, were used. They were kept in individual cages under a lighting regimen of 14L:10D and provided with feed and water ad libitum. Molting was induced by restricted feeding (25 g/d) and free access to water, which led to the cessation of egg laying after 5 to 7 d of treatment. The birds were used after 20 d of cessation of egg laying as the molting group. Molting phase was kept under this treatment until the birds were euthanized. Some molting birds were intramuscularly injected for 7 d with 1 mg of β-estradiol-benzoate (Sigma Co., St. Louis, MO) as described in our previous study (Ariyadi et al., 2013a ; EB-molting group; n = 5). The average weights of oviducts were 95.8 ± 1.6 g, 7.9 ± 0.8 g, and 32.5 ± 0.9 g in laying, molting and EB-molting groups, respectively. The hens were euthanized under anesthesia with Somnopentyl (Kyoritsu Pharmaceutical Co., Tokyo, Japan) for sample collection. The birds were handled in accordance with the regulations of Hiroshima University Animal Research Committee.
In experiment 1, the mucosal tissues of the vagina of laying hens (n = 5) were used for identification of the expression of TLR4, TLR adaptor molecules, and transcriptional factors in the vaginal mucosa. Then, the vaginal mucosa of laying, molting, and EB-molting group hens was used to examine the effects of molting and estradiol on their expression (n = 5 each).
In experiment 2, the vagina of laying hens was used (n = 5 in each LPS or inhibitor treatment analysis). The specimens of mucosal tissue were cultured as described previously (Ariyadi et al., 2013b) and stimulated by LPS together with or without inhibitors of transcriptional factors, followed by mucin expression analysis. Inhibitors used in this study were ALLN (inhibitor of IκB proteolysis; EMD Chemicals Inc., San Diego, CA), BAY-117085 (NFκB inhibitor; EMD Chemicals Inc.), U0126 (MAPK inhibitor; Promega Co., Madison, WI), and transhinone IIA (AP-1 inhibitor; Santa Cruz Biotech, Inc., Santa Cruz, CA). The mucosal tissues of the vagina were cut into small pieces (approximately 1 × 1 × 5 mm) and placed in sterile tubes for culture (3 tissue pieces per tube; Greiner Bio-one Ltd., Tokyo, Japan) containing 4 mL of culture medium with 100 ng/mL LPS, and 0 to 100 µM ALLN, BAY-117085, U0126, or transhinone IIA. The culture medium was TCM-199 medium (Nissui Pharmaceutical Co. Ltd., Tokyo, Japan) supplemented with 10% bovine serum (Biological Industries, Kibbutz Beit Haemek, Israel), 100 U/mL penicillin, and 100 µg/mL streptomycin (Cosmo Bio, Tokyo, Japan). The effects of LPS on mucin induction were confirmed by incubating tissues in the medium with LPS at a concentration of 10, 100, or 1,000 ng/mL for 3 h, as described previously (Ariyadi et al., 2013b) . Stock solution of LPS was prepared by dissolving LPS (lipopolysaccharide from Salmonella minnesota; Invitrogen, San Diego, CA) in PBS at a concentration of 5 mg/mL. Incubation was performed in a CO 2 incubator at 37°C under a humidified atmosphere with 5% CO 2 and 95% air.
Quantitative Reverse-Transcription PCR Analysis for Expression of TLR4, Adaptor Molecules, Transcriptional Factors, and Mucin
The expression of TLR4, adaptor molecules, and transcriptional factors in the vagina of hens in experiment 1 and the mucin expression in cultured tissues in experiment 2 were analyzed by reverse-transcription (RT) PCR and quantitative RT-PCR, as described previously (Ariyadi et al., 2012) . Briefly, total RNA was extracted from the tissues using Sepasol RNA I Super (Nacalai Tesque Inc., Kyoto, Japan). The extracted total RNA samples were dissolved in TE buffer (10 mM Tris, pH 8.0, with 1 mM EDTA). They were treated with 1 U of RQ1 RNase-free DNase (Promega Co., Madison, WI) on a PTC-100 programmable thermal controller (MJ Research Inc., Waltham, MA), programmed at 37°C for 45 min and 65°C for 10 min. The concentration of RNA in each sample was measured using Gene Quant Pro (Amersham Pharmacia Biotech, Cambridge, UK).
The RNA samples were reverse-transcribed using ReverTra Ace (Toyobo Co. Ltd., Osaka, Japan) according to the manufacturer's instructions. The reaction mixture (10 µL) consisted of 1 µg of total RNA, 1 × RT buffer, 1 mM dNTP mixture, 20 U RNase inhibitor, 0.5 µg of oligo(dT)20 primer, and 50 U ReverTra Ace. The reverse transcription was performed at 42°C for 30 min, followed by heat inactivation for 5 min at 99°C using the PTC-100 Programmable Thermal Controller (MJ Research Inc.).
Polymerase chain reaction was performed using Takara Ex Taq (Takara Bio Inc., Shiga, Japan) according to the manufacturer's protocol. Primers used in this study are shown in Table 1 . The PCR mixture (25 µL) contained 0.5 µL of cDNA, 1× PCR buffer, 1.5 mM MgCl 2 , 0.2 mM dNTP, 1.25 U Takara Ex Taq, and 0.5 µM each primer. Amplification was performed in a PTC-100 Programmable Thermal Controller (MJ Research Inc.) under the following conditions: 94°C for 30 s, then 34 cycles at 95°C for 30 s for denaturing, 58°C for 60 s for annealing, and 72°C for 60 s for extension. The PCR products were separated by electrophoresis on a 2% (wt/vol) agarose gel containing 0.4% (wt/vol) ethidium bromide.
Real-time PCR was performed using the Roche Light Cycler system (Roche Applied Science, Indianapolis, IN). The reaction mixture (20 µL) contained 3 µL of cDNA, 1 × SYBR Premix EX Taq (Takara Bio Inc.), and 0.5 µM of each primer. The mixture was placed into 20 µL capillaries (Roche Diagnostics GmbH, Mannheim, Germany). The cycle parameters for PCR reaction were at 95°C for 5 s and 62°C for 20 s. Real-time PCR data were analyzed by the 2 −ΔΔCT method to calculate the relative level of mRNA in each sample using RPS17 for the housekeeping gene (Livak and Schmittgen, 2001) . A sample of the vaginal mucosa of a laying hen was used as the standard for comparison among laying, molting, and EB group hens in experiment 1. In experiment 2, a sample of the vaginal mucosa incubated for 3 h without LPS was used as a standard for analysis of the effects of LPS on mucin expression. In addition, the vagina mucosa incubated for 3 h with 100 ng/mL LPS was used as the standard to examine the effects of inhibitors of transcriptional factors on the LPS-induced mucin expression. The results are expressed as relative expression obtained from the ratio of the experimental samples and the standard sample.
Statistical Analysis
The significance of the differences in the expression of TLR4, MyD88, TRIF, NFκB, cFos, and cJun among laying, molting, and EB groups in experiment 1, and expression of mucin among different inhibitor dose groups in experiment 2, was examined by one-way ANOVA followed by Tukey's test or the Kruskal-Wallis test. Differences were considered significant at P < 0.05.
RESULTS
Experiment 1
The RT-PCR analysis showed the expression of TLR4 and its adaptor molecules of MyD88 and TRIF in the vaginal mucosa of laying hens. Expression of transcriptional factors, namely, NFκB1, cFos, and cJun, was also confirmed (Figure 1) . Figure 2 shows the expression of TLR4, MyD88, and TRIF in the vaginal mucosal tissue of laying, molting, and EB-group hens. The relative expression levels of TLR4 and MyD88 were decreased to approximately 0.2-fold (Figure 2a, b) , and that of TRIF was less than 0.5-fold (Figure 2c ) in molting hens compared with those in laying hens. Their expression levels in the EB group were greater than in the molting group, although they were lower than in the laying group. Figure 3 shows differences in the gene expression levels of transcriptional factors in the vaginal mucosal tissues of laying, molting, and EB groups. The relative expression levels of cFos and cJun in the mucosal tissues were less than 0.6-fold in molting hens compared with those in laying hens (Figure 3b, c) , whereas NFκB1 gene expression was not significantly different between laying and molting hens (Figure 3a) . The expression levels of cFos and cJun were greater in the vagina of the EB group than those in the molting group ( Figure  3b and c) . The expression level of NFκB1 in the EBmolting group was not different from that in the molting group (Figure 3a) , and was lower than that in the laying group (Figure 3a) .
Experiment 2
The effects of transcriptional factor inhibitors, namely, ALLN, BAY-117085, U0126, and transhinone IIA, on LPS-induced mucin mRNA expression in the vagina of laying hens are shown in Figure 4 . The expression of mucin was increased by LPS exposure in a dose-dependent manner (Figure 4a ). The mucin expression levels were significantly reduced to approximately 0.5-fold by ALLN, BAY-117085, and U0126 at a dose of 10 µM, and further decreased at a dose of 100 µM (Figure 4b , c, and d). The expression level was also decreased by transhinone IIA at a dose of 1 µM or more (Figure 4e ).
DISCUSSION
We have examined the intracellular signaling molecules involved in the LPS stimulation of mucin expression, and the effects of molting and estrogen on their expression. Major findings were 1) that the expression of TLR4, its adaptor molecules (MyD88 and TRIF), and transcriptional factors (cFos and cJun) was significantly decreased in molting hens compared with that in laying hens, and upregulated by estrogen, and 2) that mucin expression was upregulated by LPS, whereas it was suppressed by inhibitor of transcriptional factors (IκB proteolysis, NFκB, MAPK, and AP-1 inhibitor).
It is accepted that there are 2 different TLR signaling pathways, namely, MyD88-dependent and TRIF- dependent pathways (Kawai and Akira, 2010) . The current results showed that both MyD88 and TRIF were expressed in the vaginal mucosa, suggesting that both pathways for TLR signaling are formed in that tissue. Kogut et al. (2012) reported that infection by Salmonella enteritidis induced the attraction of both MyD88-dependent and TRIF-dependent TLR signaling pathways. It is reported in mammals that TLR4 is unique in that it uses both MyD88-and TRIF-dependent pathways (Kogut et al., 2012) . However, in chicken, LPS failed to stimulate the TLR4-TRAM-TRIF pathway (Keestra and van Putten, 2008; de Zoete et al., 2010) , probably due to the absence of TRAM that bridges TLR4 and TRIF. Thus, although the expression of MyD88 and TRIF was identified, mucin induction by LPS might be mediated by the TLR4 and MyD88 pathway. The TRIF may function as an adaptor of other TLRs to recognize microbe components. The MyD88 signaling pathway may be linked to the activation of nuclear transcription factors including NFκB and AP1 (cFos and cJun; Kogut et al., 2012; Keestra et al., 2013) . The current results showed the expression of NFκB, cFos, and cJun in the vaginal mucosa, suggesting the possibility that these nuclear transcriptional factors may participate in the regulation of mucin expression by the MyD88 signaling pathway.
The expression of TLR4 and MyD88 as well as TRIF was reduced in the molting group and upregulated by EB. Thus, the ability to recognize LPS by TLR4 and signaling by MyD88 may be decreased in association with oviductal regression due to the decline in the level of circulating estrogen during molting. The cFos and cJun expression in molting hens was lower than in laying hens, and recovered to the same level as in laying hens by injection with EB. In contrast, NFκB1 expression was not significantly different between laying and molting hens, and the expression was not recovered by EB. In mammals, macrophage estradiol-17β prevents its nuclear translocation (Ghisletti et al., 2005) . Thus, estrogen may not enhance the transcriptional activity by NFκB. It is likely that the expression level of AP1 transcriptional factor declines during molting due to the lower level of circulating estrogen. However, the expression of NFκB may not be positively correlated with the level of estrogen.
The mucin expression was upregulated by LPS, supporting our previous report (Ariyadi et al., 2013b) . The effect of LPS on mucin expression was suppressed by inhibitors of NFκB-dependent transcription, namely, an inhibitor of IκB proteolysis (ALLN) and an inhibitor of NFκB nuclear translocation (BAY-117086). In addition, the effects of LPS were suppressed by inhibitors of the transcriptional process by MAP kinase and AP1, namely, an inhibitor of MAP kinase (U0126) and an inhibitor of AP1 (transhinone IIA). These results suggest that the induction of mucin expression by LPS is mediated by both NFκB-dependent and AP1-dependent pathways. Shen et al. (2008) reported that synergistic induction of mucin5AC in mixed infections by Hemophilus influenzae and Streptococcus pneumoniae is regulated by AP-1 in the human colon and middle ear epithelial cells. It is also reported that mucin5AC hypersecretion was consistent with activation of the AP-1 and NFκB signaling pathways downstream of epidermal growth factor and TLR4 in rat airway cells (Nie et al., 2012) . More recently, Yang et al. (2013) reported that crotonaldehyde, a toxic α,β-unsaturated aldehyde, stimulated the inflammatory response by enhancing IL-8 release from human airway epithelial cells by both NFκB and AP-1 pathways. Therefore, it is possible that LPS stimulation activates both NFκB and AP-1 pathways to induce mucin expression in hen vagina, as observed in this study. However, the factors regulating those NFκB and AP-1 pathways in the vagina cells may be different between the 2 pathways because expression of AP-1 factors (cFos and cJun) declined during molting and was upregulated by estrogen, but NFκB expression did not show such changes with oviductal stage difference and estrogen treatment.
It is generally accepted that the mucin layer on the surface of mucosal tissue forms a mucosal barrier in combination with immune cells and epithelial junctions (Linden et 2013a). The current results showing the existence of a TLR4 to MyD88 signal pathway and an NFκB and AP-1 transcriptional pathway to induce mucin expression in response to LPS suggests that infection of gramnegative bacteria upregulates mucin expression. The TRIF, another TLR adaptor, identified in the vaginal mucosa may play roles as an adaptor molecule for TLR other than TLR4. Further studies are necessary to determine whether recognition of microbe components other than LPS by different TLR that activate nuclear transcriptional factors through a TRIF-dependent pathway induces mucin expression.
In conclusion, MyD88-dependent and TRIF-dependent pathways for TLR signaling exist in the vagina. Expression of TLR adaptor molecules and transcriptional factors is reduced in the molting phase compared with that in laying, probably due to the decline of the estrogen level. Transcriptional factors of NFkB and AP-1 may participate in the induction of mucin expression by LPS. The mucin expression system in response to LPS may play a role in the mucosal barrier against infection.
